Funds holding Edgewise Therapeutics Inc
215 funds declare a position · 44 ETFs and 171 other funds · 659.2M $· 71.3M SEK· 1.7M € · US28036F1057
Each line carries its report date.
| Rank | Fund | Shares | Value | Weight | |
|---|---|---|---|---|---|
| 201 | Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 230 | 7.2K $ | 0.00 % | as of Mar 31, 2026 · Original filing |
| 202 | PROFUND VP ULTRA SMALL CAP ProFunds | 226 | 7.1K $ | 0.05 % | as of Mar 31, 2026 · Original filing |
| 203 | PROFUND VP SMALL CAP ProFunds | 171 | 5.4K $ | 0.05 % | as of Mar 31, 2026 · Original filing |
| 204 | Russell 2000 Fund Rydex Series Funds | 152 | 4.8K $ | 0.04 % | as of Mar 31, 2026 · Original filing |
| 205 | Kennedy Capital Small Cap Growth Fund INVESTMENT MANAGERS SERIES TRUST II | 143 | 4.5K $ | 0.91 % | as of Mar 31, 2026 · Original filing |
| 206 | SMALL-CAP PROFUND ProFunds | 123 | 3.8K $ | 0.05 % | as of Apr 30, 2026 · Original filing |
| 207 | Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 116 | 3.7K $ | 0.12 % | as of Mar 31, 2026 · Original filing |
| 208 | Russell 2000 1.5x Strategy Fund Rydex Series Funds | 91 | 2.9K $ | 0.05 % | as of Mar 31, 2026 · Original filing |
| 209 | ProShares Hedge Replication ETF ProShares Trust | 69 | 2.1K $ | 0.01 % | as of Feb 28, 2026 · Original filing |
| 210 | Goldman Sachs MSCI World Private Equity Return Tracker ETF Goldman Sachs ETF Trust | 35 | 1.1K $ | 0.00 % | as of Feb 28, 2026 · Original filing |
| 211 | E*TRADE No Fee Total Market Index Fund E Trade Trust | 30 | 928.8 $ | 0.00 % | as of Apr 30, 2026 · Original filing |
| 212 | ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 22 | 669.7 $ | 0.06 % | as of Feb 28, 2026 · Original filing |
| 213 | Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 18 | 567 $ | 0.02 % | as of Mar 31, 2026 · Original filing |
| 214 | VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 1.1M € | 1.28 % | as of Dec 31, 2025 · Original filing | |
| 215 | LAGO ERIE, SICAV, S.A. GESALCALA, S.A., S.G.I.I.C. | 634.9K € | 1.70 % | as of Dec 31, 2025 · Original filing |
Institutional managers
207 managers declare this company to the SEC (Form 13F). These positions are not counted in the totals above: a manager and its own funds file separately.
| Manager | Shares | Value | |
|---|---|---|---|
| ORBIMED ADVISORS LLC | 15,518,492 | 488.8M $ | as of Mar 31, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | 10,428,437 | 328.5M $ | as of Mar 31, 2026 |
| Paradigm Biocapital Advisors LP | 7,365,038 | 232M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 6,575,940 | 207.1M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 6,472,991 | 203.9M $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 5,915,556 | 186.3M $ | as of Mar 31, 2026 |
| NOVO HOLDINGS A/S | 5,350,000 | 168.5M $ | as of Mar 31, 2026 |
| Driehaus Capital Management LLC | 4,477,942 | 141.1M $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 4,430,263 | 139.6M $ | as of Mar 31, 2026 |
| PERCEPTIVE ADVISORS LLC | 4,423,974 | 139.4M $ | as of Mar 31, 2026 |
| Cormorant Asset Management, LP | 3,260,000 | 102.7M $ | as of Mar 31, 2026 |
| BRAIDWELL LP | 2,347,583 | 73.9M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 2,246,028 | 70.7M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,789,819 | 56.4M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 1,716,823 | 54.1M $ | as of Mar 31, 2026 |
| MPM BIOIMPACT LLC | 1,660,696 | 52.3M $ | as of Mar 31, 2026 |
| Integral Health Asset Management, LLC | 1,600,000 | 50.4M $ | as of Mar 31, 2026 |
| Bellevue Group AG | 1,528,518 | 48.1M $ | as of Mar 31, 2026 |
| Soleus Capital Management, L.P. | 1,449,915 | 45.7M $ | as of Mar 31, 2026 |
| ALLIANCEBERNSTEIN L.P. | 1,722,169 | 42.7M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 1,327,360 | 41.8M $ | as of Mar 31, 2026 |
| UBS Group AG | 1,311,125 | 41.3M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 1,219,717 | 38.4M $ | as of Mar 31, 2026 |
| AMERICAN CENTURY COMPANIES INC | 1,147,176 | 36.1M $ | as of Mar 31, 2026 |
| FMR LLC | 1,017,052 | 32M $ | as of Mar 31, 2026 |